Skip to content

Author

Eugen Feist

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

CAR T cells for HLA desensitization: a new era in kidney transplantation

In a recent study published in the New England Journal of Medicine , autologous CD19-and BCMA-directed chimeric antigen receptor (CAR) T-cell therapy was evaluated as a desensitization strategy in two highly sensitized kidney transplant candidates. 1 In this safety run-in cohort of an ongoing phase I clinical trial (NC...

P. Mertens, Eugen Feist, D. Mougiakakos · 0 citations
Open access Aug 2026

Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series.

Anti-CD19 CAR T cell therapy represents an emerging therapeutic approach for generalized, treatment-refractory myasthenia gravis (MG), a predominantly B-cell-mediated autoimmune disease for which durable treatment-free remission remains an unmet clinical goal. Despite recent advances, current targeted therapies general...

T. Hegelmaier, J. Motte, Denise Walther et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.